Efficacy of Autologous Growth Factors in Lumbar Intertransverse Fusions
Authors:
- Bradley K. WeinerBWBradley K. Weiner
- Matthew WalkerMWMatthew Walker
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 28 (17) , 1968-1970
Abstract
A retrospective, consecutive series with “blinded” radiographic review was performed to evaluate two groups undergoing lumbar fusion: one with and one without autologous growth factors (AGF). AGF has been shown to promote bone formation in vitro and in vivo in animal studies. Accordingly, it has been promoted to augment lumbar intertransverse fusions. To date, however, no controlled studies have been performed to assess its ability to do so in humans. This article presents the first such study. Two groups were studied. The control group consisted of 27 consecutive patients who underwent a single-level intertransverse lumbar fusion using iliac crest bone graft for either degenerative disk disease (DDD) or degenerative spondylolisthesis from January 1999 to November 1999. The AGF group consisted of 32 consecutive patients undergoing an identical procedure for the same indications with iliac crest bone graft augmented with AGF from January 2000 to November 2000. Fusions were assessed radiographically at 1 and 2 years by two independent spine surgeons on AP and lateral flexion/extension radiographs. The fusion rate for the control group was 24 of 27, or 91%. The fusion rate for the AGF group was 18 of 32 or 62%. In this study, the use of AGF resulted in inferior rates of arthrodesis compared with autogenous bone graft alone. Although it is important to note there are several techniques available to produce AGF and that the concentration of AGF may differ between individuals, based on the authors’ findings, they cannot recommend the use of AGF for this indication until further clinical studies, perhaps altering these variables, prove otherwise.Keywords
This publication has 14 references indexed in Scilit:
- Cervical Spine Injuries in Athletes: Current Return-to-Play CriteriaOrthopedics, 2001
- Use of autologous growth factors in lumbar spinal fusionBone, 1999
- Involvement of platelets in stimulating osteogenic activityJournal of Orthopaedic Research, 1995
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Stimulation of Bone Matrix Appositionin Vitroby Local Growth Factors: A Comparison between Insulin-like Growth Factor I, Platelet-Derived Growth Factor, and Transforming Growth Factor β*Endocrinology, 1990
- Interactions of Growth Factors Present in Bone Matrix with Bone Cells: Effects on DNA Synthesis and Alkaline PhosphataseGrowth Factors, 1990
- Effects of platelet‐derived growth factor on bone formation in vitroJournal of Cellular Physiology, 1989
- In VivoStimulation of Bone Formation by Transforming Growth Factor-βEndocrinology, 1989
- Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formationCalcified Tissue International, 1988
- Human Platelet-Derived Transforming Growth Factor-βStimulates Parameters of Bone Growth in Fetal Rat Calvariae*Endocrinology, 1986